Literature DB >> 19006486

Idiopathic inflammatory myopathies.

V S Limaye1, P Blumbergs, P J Roberts-Thomson.   

Abstract

The idiopathic inflammatory myopathies are a group of systemic autoimmune syndromes characterized by striated muscle inflammation. Here, we discuss the clinical features of this group of conditions and review the recent developments in the understanding of the pathogenesis and immunogenetics of the idiopathic inflammatory myopathies. The role of myositis-specific autoantibodies and their clinical significance and an overview of management are also provided.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19006486     DOI: 10.1111/j.1445-5994.2008.01822.x

Source DB:  PubMed          Journal:  Intern Med J        ISSN: 1444-0903            Impact factor:   2.048


  7 in total

1.  A three-way interplay of DR4, autoantibodies and synovitis in biopsy-proven idiopathic inflammatory myositis.

Authors:  Vidya S Limaye; Sue Lester; Peter Bardy; Philip Thompson; Sally Cox; Peter Blumbergs; Peter Roberts-Thomson
Journal:  Rheumatol Int       Date:  2010-12-02       Impact factor: 2.631

2.  Inflammatory myopathy in a patient with postural and kinetik tremor.

Authors:  Daniele Orsucci; Michelangelo Mancuso; Greta Alì; Valeria Calsolaro; Giulia Ricci; Sara Gori; Gabriele Siciliano
Journal:  Neurol Sci       Date:  2011-05-10       Impact factor: 3.307

3.  Prevalence of other connective tissue diseases in idiopathic inflammatory myopathies.

Authors:  Adam Maundrell; Susanna Proudman; Vidya Limaye
Journal:  Rheumatol Int       Date:  2019-08-05       Impact factor: 2.631

Review 4.  Tumor necrosis factor-alpha as a potential therapeutic target in idiopathic inflammatory myopathies.

Authors:  Joerg-Patrick Stübgen
Journal:  J Neurol       Date:  2011-01-21       Impact factor: 6.682

5.  Tacrolimus rescue therapy for severe respiratory failure in the anti-synthetase syndrome.

Authors:  Amy L Rigby; Marshall Plit; Allan R Glanville
Journal:  Respirol Case Rep       Date:  2014-02-25

Review 6.  Immune Checkpoint Inhibitor-Related Myositis: From Biology to Bedside.

Authors:  Antonio G Solimando; Lucilla Crudele; Patrizia Leone; Antonella Argentiero; Matteo Guarascio; Nicola Silvestris; Angelo Vacca; Vito Racanelli
Journal:  Int J Mol Sci       Date:  2020-04-26       Impact factor: 5.923

7.  Recovering autonomy is a key advantage of home-based immunoglobulin therapy in patients with myositis: A qualitative research study.

Authors:  Patrick Chérin; Taylor Pindi Sala; Pierre Clerson; Annaïk Dokhan; Yann Fardini; Martin Duracinsky; Jean-Charles Crave; Olivier Chassany
Journal:  Medicine (Baltimore)       Date:  2020-02       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.